World s first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situations in the age group of 18 and above.
Bharat Biotech Tweeted on November 28, 2022, that iNCOVACC became the world's first intranasal COVID-19 vaccine to receive both primary series and Heterologous booster approval in India. Previously, ANI Tweeted on November 25, 2022, the Drugs Controller General of India had approved Bharat Biotech's Intranasal 'Five Arms' booster dose of iNCOVACC.
iNCOVACC, on Tuesday, became the world s first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced in a press release.